These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11797509)
1. [Kinetics and dosimetry of monoclonal antibody MAb-170: evaluation of possibilities for intraperitoneal radioimmunotherapy]. Alexander C; Holländer M; Schmidt W; Kirsch CM Nuklearmedizin; 2001 Dec; 40(6):207-14. PubMed ID: 11797509 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy. Buchmann I; Kull T; Glatting G; Bunjes D; Hale G; Kotzerke J; Rattat D; Dohner H; Reske SN Eur J Nucl Med Mol Imaging; 2003 May; 30(5):667-73. PubMed ID: 12599012 [TBL] [Abstract][Full Text] [Related]
3. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488 [TBL] [Abstract][Full Text] [Related]